By John Eggerton, Broadcasting & Cable Online, 5-9-19
Drug companies will have to disclose the list price to patients for prescription drugs and biological products in their TV (broadcast, cable and satellite) and online ads. That is according to a final rule published by the Department of Health and Human Services, part of the Trump Administration’s effort to lower those prices and the first final rule in that effort.
HHS pointed out that while drug companies have to disclose the “major side effects” a drug can have on a user’s health, it is not required to disclose the impact it can have on wallets and purses. That is changing as a way to try and lower drug prices. “It will provide manufacturers with an incentive to reduce their list prices by exposing overly costly drugs to public scrutiny,” HHS said. » Read More